ASHM

Twitter  LinkedIn  Facebook  Vimeo  Search 

Contact Us |  Careers    MyASHM 

   

  • Register
  • Cart ()
  • All
  • Website
  • Resources
  • Courses
  • Forums
  • HIV
    • HIV
    • PrEP
    • HIV Prescriber Program
    • Find an HIV s100 Prescriber
    • HIV Training
    • Undetectable = Untransmittable
    • HIV Strategies & Policies
  • Hepatitis B
    • Hepatitis B
    • HBV Prescriber Program
    • Find an HBV s100 Prescriber
    • Hepatitis B Training
    • HBV Strategies & Policies
  • Hepatitis C
    • Hepatitis C
    • Management and Treatment
    • Trained Community Medical Practitioners
    • Hepatitis C Training
    • HCV Strategies + Policies
    • Aus GPs End Hep C
    • Hepatitis C Elimination INHSU Declaration
  • Sexual Health
    • Sexual Health
    • Australasian Sexual Health Alliance
    • STI Strategies & Policies
    • STI Resources
    • STI Training
  • International
    • International
    • International Services
    • International Projects
    • Consultancy Pool
    • International Resources
    • Regional Network
    • Donate
  • Programs
    • Programs
    • Nursing Program
    • Aboriginal and Torres Strait Islander Program
    • Community Pharmacy
    • Viral Hepatitis Mapping Project
    • Our work in QLD
    • Our work in VIC
    • Culturally and Linguistically Diverse Program
    • Our work in HTLV-1
  • Resources
    • Resources
    • HIV Resources
    • HBV Resources
    • HCV Resources
    • STI Resources
  • Conferences
    • Conferences
    • Conferences We Organize
    • Our Conference Services
    • Our Team
    • Our Clients
    • Scholarships and Awards
    • Levinia Crooks Emerging Leader Award
    • Sector Events
  • Training
    • Training
    • Training Locator Map: Enter your Address or City
    • Kirby Seminar Talks
    • ASHM/SSHC HIV/Sexual Health Clinical Education Session
    • Contact Us
    • Training Calendar
  • About

ASHM Logo 2020

  • HIV
    • HIV
    • PrEP
    • HIV Prescriber Program
    • Find an HIV s100 Prescriber
    • HIV Training
    • Undetectable = Untransmittable
    • HIV Strategies & Policies
  • Hepatitis B
    • Hepatitis B
    • HBV Prescriber Program
    • Find an HBV s100 Prescriber
    • Hepatitis B Training
    • HBV Strategies & Policies
  • Hepatitis C
    • Hepatitis C
    • Management and Treatment
    • Trained Community Medical Practitioners
    • Hepatitis C Training
    • HCV Strategies + Policies
    • Aus GPs End Hep C
    • Hepatitis C Elimination INHSU Declaration
  • Sexual Health
    • Sexual Health
    • Australasian Sexual Health Alliance
    • STI Strategies & Policies
    • STI Resources
    • STI Training
  • International
    • International
    • International Services
    • International Projects
    • Consultancy Pool
    • International Resources
    • Regional Network
    • Donate
  • Programs
    • Programs
    • Nursing Program
    • Aboriginal and Torres Strait Islander Program
    • Community Pharmacy
    • Viral Hepatitis Mapping Project
    • Our work in QLD
    • Our work in VIC
    • Culturally and Linguistically Diverse Program
    • Our work in HTLV-1
  • Resources
    • Resources
    • HIV Resources
    • HBV Resources
    • HCV Resources
    • STI Resources
  • Conferences
    • Conferences
    • Conferences We Organize
    • Our Conference Services
    • Our Team
    • Our Clients
    • Scholarships and Awards
    • Levinia Crooks Emerging Leader Award
    • Sector Events
  • Training
    • Training
    • Training Locator Map: Enter your Address or City
    • Kirby Seminar Talks
    • ASHM/SSHC HIV/Sexual Health Clinical Education Session
    • Contact Us
    • Training Calendar
  • About
  • Australia | Supporting HIV, Viral Hepatitis and Sexual Health Workforce
  • Community
  • Blogs2
  • Blog Archive
  • October 2018

Blogs2 October 2018

  1. Prevention for bacterial vaginosis recurrence

    Lauren Gill – Wed, 31 Oct 2018 21:00:00 GMT – 0

    A report on Lenka Vodstrcil's presentation "Sexual Behaviours and Past Bacterial Vaginosis (BV) Contribute Significantly to BV Recurrence in Women Randomised to the Oral-Contraceptive Pill"

    Such an interesting presentation on Bacterial Vaginosis (BV) which is a common presentation for women with symptoms in sexual health services. I have encountered many women over the years who complain of BV symptoms which often return time and time again despite being treated.

    Continue reading…

    • sexual health
  2. Mycoplasma genitalium is an important cause of urethritis in all men and macrolide resistance is common

    Miranda Sherley – Wed, 31 Oct 2018 21:00:00 GMT – 0

    A report on Ruthy McIver's presentation "Men who have sex with men with Mycoplasma Genitalium-Positive Non-Gonococcal Urethritis are more likely to have macrolide resistant strains than men with only female partners"

    This session contained a wide mix of 5-10 min presentations dealing with clinical research. Ruthy McIver’s presentation looked at the prevalence of Mycoplasma genitalium (MG) in men with non-gonococcal urethritis (NGU), both men who have sex with men (MSM) and men with female partners only (MSW), presenting to Sydney Sexual Health Centre (SSHC).

    Continue reading…

    • sexual health
    • STI Treatment
  3. PrEP: Where are we up to

    Jane Hunt – Tue, 30 Oct 2018 21:00:00 GMT – 0

    A report on Sheena McCormack's presentation "PrEP: What's happening in Europe and the world in general"

    This presentation outlined the current status of PrEP uptake around the world. It touched on some of the challenges and outlined some of the anticipated new medications and new modes of delivery of PrEP.

    The overwhelming message is that PrEP using TDF/FTC either daily or on demand is effective in averting new HIV infections ( PREVENIR study 85 HIV infections averted; EPIC N.S.W. 31.5% decline in recent infections compared with previous year, 25% reduction attributed to  PrEP; Soho London clinic 80% decline in HIV cases since 2015).

    Continue reading…

    • HIV
    • PrEP
  • ‹ Newer
  • Older ›

Options

Back to Blogs list RSS Feed

Search Blogs

Tags

4th 90 1 909090 3 Aboriginal communities 6 Accessability 5 Adolescents 2 AIDS 3 anal cancer 1 Australia 2 bNab 3 Breastfeeding 2 CALD 7 chemsex 3 chlamydia 3 Clinical assessment 1 clinical guidelines 2 Coinfection 1 Co-infection 1 Community 4 Contraception 1 coordinated approach 2 Criminalisation 1 CROI 2018 26 cure 8 DAA 9 DDIs 2 early testing 1 Education 1 elimination 5 GESA 1 GPs 11 HAND 2 HBV 7 HCV 47 Healthcare Systems 3 HealthELink 1 Hepatitis A 1 hepatitis b 8 HIV 42 HIV and Ageing 5 HIV and Pregnancy 3 HIV co-morbidities 6 HIV Criminalisation 2 HIV Cure 6 HIV Monotherapy 1 HIV Pharmacy 4 HIV PrEP 20 HIV PrEP on-demand 1 HIV self-testing 2 HIV Transmission 11 HIV Treatment 26 HIVAUS18 12 HIVGlasgow 5 HTLV-1 1 Inequality 5 Infants 1 international 1 kplhs 5 liberation 1 Life expectancy 1 lived experience 1 Liver Cancer 3 Mental health 8 micro elimination 1 Microbiome 1 Micro-elimination 1 MSM 11 multidisciplinary care 2 New treatments 3 no one left behind 2 outreach 3 Peer-based 5 Phylogenetics 2 PLWHIV 19 policy 2 PrEP 14 PrEP and STIs 7 prescribing 1 Prison Setting 3 PWID 8 QLD 1 Rapid treatment 1 remote 4 removing barriers 3 Resilience 1 Sex Work 1 sexual health 13 social media 1 Social Policy 3 STI Treatment 6 Stigma 4 Stigma and Discrimination 2 Switching 2 systemic reviews 1 t cells 1 TaSP 1 TB 1 Testing 5 Transgender 5 Treatment and management 4 treatment failure 1 Tuberculosis 2 Viral Hepatitis 6 Viral Hepatitis Conference 11 Weight gain 1 WHO 3 Women 8 Young people 2

Archive

November 2019 3 September 2019 21 August 2019 13 July 2019 16 March 2019 4 November 2018 28 October 2018 3 September 2018 11 August 2018 32 July 2018 36 June 2018 21 March 2018 26

ASHM

  • Home

    • Products
    • News
    • Store Locator
    • Careers
    • Sitemap
  • Community

    • Ideas
    • Blogs2

Privacy  |  Terms & Conditions  |  Contact Us  |  Copyright

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine  |  ABN 48 264 545 457  |  CFN 17788  |  Copyright © 2020. ASHM